ProShare Advisors
OSIR

ProShare Advisors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

ProShare Advisors’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-23,690
Closed -$118K – 1782
2016
Q3 		$118K Sell
23,690
-4,390
-16% -$22.5K ﹤0.01% 1406
2016
Q2 		$143K Buy
28,080
+434
+2% +$2.34K ﹤0.01% 1484
2016
Q1 		$158K Sell
27,646
-2,838
-9% -$19.8K ﹤0.01% 1460
2015
Q4 		$316K Buy
30,484
+2,398
+9% +$32.5K ﹤0.01% 1269
2015
Q3 		$519K Sell
28,086
-1,799
-6% -$34.7K 0.01% 927
2015
Q2 		$582K Sell
29,885
-1,433
-5% -$25.4K 0.01% 1030
2015
Q1 		$551K Buy
31,318
+4,525
+17% +$76K 0.01% 1132
2014
Q4 		$428K Buy
26,793
+1,587
+6% +$21.2K 0.01% 1287
2014
Q3 		$317K Sell
25,206
-4,802
-16% -$68.5K ﹤0.01% 1682
2014
Q2 		$469K Sell
30,008
-12,686
-30% -$187K 0.01% 1625
2014
Q1 		$561K Buy
42,694
+26,618
+166% +$416K 0.01% 1779
2013
Q4 		$259K Sell
16,076
-5,985
-27% -$95.4K ﹤0.01% 1204
2013
Q3 		$367K Buy
22,061
+5,070
+30% +$75K 0.01% 1733
2013
Q2 		$171K Buy
+16,991
New +$179K ﹤0.01% 2097

Other funds holding OSIR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ProShare Advisors's OSIR Position: Q4 2016 in Review

ProShare Advisors sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q4 2016, closing a stake of 23,690 shares — an estimated $118K sold.

ProShare Advisors first reported a position in OSIR in Q2 2013 and held it in 14 quarters. The position peaked at $582K in Q2 2015. 64 funds tracked by Wall St. Rank hold OSIR as of Q4 2016.

  • ProShare Advisors reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • ProShare Advisors sold 23,690 Osiris Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $118K.
  • ProShare Advisors first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 14 quarters.
  • ProShare Advisors's Osiris Therapeutics, Inc. Common Stock position peaked at $582K in Q2 2015.
  • 64 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2016.

Based on ProShare Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.